Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02319369
Title Study to Evaluate the Safety, Tolerability and Pharmacokinetics of DS-3032b in Hematological Malignancies
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Daiichi Sankyo Inc.

chronic lymphocytic leukemia

bone marrow cancer

acute lymphoblastic leukemia

acute myeloid leukemia


Milademetan Tosylate

Age Groups: adult
Covered Countries USA

No variant requirements are available.